Impact of intensive therapy with continuous subcutaneous insulin infusion on quality of life in patients with type 1 diabetes

Journal of Applied Biobehavioral Research

Volumn 15, Issue 1, 2010, Pages 1-19

  Ortiz, María Teresa Anarte ^a   Díaz, Francisco Félix Caballero ^a   Romero, Alberto Machado ^b   Ruiz de Adana Navas, María Soledad ^c   Domínguez López, Marta ^c   Gonzalo Marín, Montserrat ^c   Guerrero, María José Tapia ^c   Hernández, Sergio Valdés ^c   González Romero, Stella ^c   Rojo Martínez, Gemma ^c   Escofet, Federico J Casimiro Soriguer ^c  

^a Hospital Punta Europa   (Spain)

^b HOSPITAL PUNTA DE EUROPA   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956123761     PISSN: 10712089     EISSN: 17519861     Source Type: Journal    
DOI: 10.1111/j.1751-9861.2010.00049.x     Document Type: Article

References (47)

1. Anarte M T, Machado A, Ruiz de Adana M S, Domínguez M, Carreira M, González Molero I. Personalidad y adherencia al tratamiento con infusor subcutáneo de insulina y monitorización continua de glucosa en pacientes con diabetes mellitus tipo 1. Avances en Diabetología 2009, 25:394-398.
2. Barnard K D, Lloyd C E, Skinner T C. Systematic literature review: Quality of life associated with insulin pump use in type 1 diabetes. Diabetic Medicine 2007, 24:607-617.
3. Bell D S, Ovalle F. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. Endocrine Practice 2000, 6:357-360.
4. Bode B W, Steed R D, Davidson P C. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996, 19:324-327.
5. Boland E A, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion: A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999, 22:1779-1784.
6. Bott U, Muhlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998, 21:757-769.
7. Bruttomesso D, Pianta A, Crazzolara D, Scaldaferri E, Lora L, Guarneri G. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: Efficacy, acceptability and quality of life. Diabetic Medicine 2002, 19:628-634.
8. Cella D F, Diennen K, Arnason B, Reder A, Webste M, Karabastos B. Validation of the functional assessment of multiple sclerosis quality of life instrument. American Academy of Neurology 1999, 47:129-139.
9. Chantelau E, Schiffers T, Schutze J, Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Patient Education and Counseling 1997, 30:167-175.
10. Chorot P, Navas J. Escala multidimensional de locus de control hacia la salud (MHLC). Mimeograma 1995, Madrid, Universidad Nacional de Educación a Distancia (UNED)
11. Colquitt J L, Green C, Sidhu M K, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technology Assessment 2004, 8:1-171.
12. Delamater A, Jacobson A M, Barbara A, Daniel C, Fisher L, Lustman P. Psychosocial therapies in diabetes. Report of the psychosocial therapies working group. Diabetes Care 2001, 24:1286-1292.
13. Fox L A, Buckloh L M, Smith S D, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005, 28:1277-1281.
14. Guttmann-Bauman I, Flaherty B P, Strugger M, McEvoy R C. Metabolic control and quality-of-life self-assessment in adolescents with IDDM. Diabetes Care 1998, 21:915-918.
15. Haakens K, Hanssen K F, Dahl-Jorgensen K, Vaaler S, Aagen E S, Mosand R. Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients: A comparison of metabolic control, acute complications and parent preferences. Journal of Internal Medicine 1990, 228:457-464.
16. Hoogma R P, Hammond P J, Gommis R, Kerr D, Bruttomesso D, Bouter K P. Comparison of effects of CSII and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: Results of the 5-nations trial. Diabetic Medicine 2006, 23:141-147.
17. Hoogma R P, Spijker A J, van Doorn-Scheele M, van Doorn T T, Michels R P, van Doorn R G. Quality of life and metabolic control in patients with diabetes mellitus type I treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. The Journal of Medicine 2004, 62:383-387.
18. Kamoi K, Miyakoshi M, Maruyama R. A quality of life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: A prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion. Diabetes Research and Clinical Practice 2004, 64:19-25.
19. Linkeschova R, Raoul M, Bott U, Berger M, Spraul M. Less severe hypoglycaemia, better metabolic control and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabetic Medicine 2002, 19:746-751.
20. Litton J, Rice A, Friedman N, Oden J, Lee M M, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. Journal of Pediatrics 2002, 141:490-495.
21. Lustman P J, Griffith L S, Clouse R E. Depression in adults with diabetes. Seminary Clinical Neuropsychiatry 1997, 2:15-23.
22. McMahon S K, Airey F L, Marangou D A, McElwee K J, Carne C L, Clarey A J. Insulin pump therapy in children and adolescents: Improvements in key parameters of diabetes management including quality of life. Diabetes Medicine 2005, 22:92-96.
23. Mednick L, Cogen F R, Streisand R. Satisfaction and quality of life in children with type 1 diabetes and their parents following transition to insulin pump therapy. Children's Health Care 2004, 33:169-183.
24. Millán M M, Reviriego J, del Campo J. Reevaluación de la versión española del Cuestionario Diabetes Quality of Life (EsDQOL). Endocrinología y Nutrición 2002, 49:322-324.
25. Mora E, Beléndez M, Ballester M J, Giralt P, Contreras M R, Mora M R. Evaluación de la calidad de vida en niños y adolescentes con diabetes tipo 1. Avances en Diabetología 2005, 21:151-160.
26. O'Neil K J, Jonnalagadda S S, Hopkins B L, Kicklighter J R. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics. Journal of the American Dietetic Association 2005, 105:85-91.
27. Peyrot M, Rubin R R. Validity and reliability of an instrument for assessing health related quality of life and treatment preferences. Diabetes Care 2005, 28:53-58.
28. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type I diabetes: Meta-analysis of randomised controlled trials. British Medical Journal 2002, 321:1-16.
29. Ramos J A. La validez predictiva del Inventario para la Depresión de Beck en castellano. Actas Luso-Españolas de Neurología-Psiquiatría y Ciencias Afines 1986, 14:47-50.
30. Retnakaran R, Hochman J, DeVries J H, Hanaire-Broutin H, Heine R J, Melki V. Continuous subcutaneous insulin infusion versus multiple daily injections. The impact of baseline A1c. Diabetes Care 2004, 27:2590-2596.
31. Rodrigues I A S, Reid K, Ismail K, Amiel S A. Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in type 1 diabetes mellitus: A clinical audit in a specialist service. Diabetic Medicine 2005, 22:842-849.
32. Sanz J, García-Vera M P, Espinosa R, Fortín M, Vázquez C. Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clínica y Salud 2005, 16:121-142.
33. Schalock R L, Verdugo M A. Calidad de vida. Manual para profesionales de la educación, salud y servicios sociales 2003, Madrid, Alianza Editorial
34. Schiffrin A, Desrosiers M, Mofflatt M, Belmonte M. Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. Journal of Pediatrics 1983, 103:522-527.
35. Seisdedos N. Cuestionario de ansiedad estado-rasgo. Adaptación española 1988, Madrid, TEA
36. Reliability and validity of a Diabetes Quality-of-Life Measure (DQOL) for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988, 11:725-732. The Diabetes Control and Complications Trial Research Group
37. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993, 329:977-985. The Diabetes Control and Complications Trial Research Group
38. Implementation of treatment protocols in the diabetes control and complications trial. Diabetes Care 1995, 18:361-376. The Diabetes Control and Complications Trial Research Group
39. The development of the World Health Organization Quality of Life Assessment Instrument (the WHOQoL). Quality of life assessment: International perspectives 1994, 41-60. Orley JKuyken W. The World Health Organization Quality of Life Group, Eds, Heidleberg, Springer-Verlag
40. Ethical principles for medical research involving human subjects. 1964, The World Medical Association, 18th WMA General Assembly, Helsinki. Finland, and amended by the: 29th WMA General Assembly, Tokyo, Japan, October 1975; 35th WMA General Assembly, Venice, Italy, October 1983; 41st WMA General Assembly, Hong Kong, September 1989; 48th WMA General Assembly, Somerset West, Republic of South Africa, October 1996; 52nd WMA General Assembly, Edinburgh, Scotland, October 2000; 53rd WMA General Assembly, Washington 2002; 55th WMA General Assembly, Tokyo 2004; 59th WMA General Assembly, Seoul, October 2008
41. Torres A, Hernández E, Ortega H. Validez y reproducibilidad del Inventario para Depresión de Beck en un hospital de cardiología. Salud Mental 1991, 14:1-6.
42. Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin Lispro. Diabetes Care 2001, 24:1722-1727.
43. Valenzuela J M, Patino A M, McCullough J, Ring C, Sanchez J, Eidson M. Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes. Journal of Pediatric Psychology 2006, 31:650-660.
44. Wallston K A, Strudler B. Health locus of control scales. Research with the Locus of Control Construct 1981, 1:189-243.
45. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003, 112:559-564.
46. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care 2003, 4:1079-1087.
47. Wilson D M, Buckingham B A, Kunselman E L, Sullivan M M, Paguntalan H U, Gitelman S E. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005, 28:15-19.